StonvexLoading…
StonvexStonvexStonvexCore line items from HSTM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $304.06M | $291.65M | $279.06M | $266.83M |
Operating Income | $20.24M | $21.29M | $16.02M | $12.45M |
Net Income | $18.34M | $20.01M | $15.21M | $12.09M |
EPS (Diluted) | $0.61 | $0.66 | $0.50 | $0.39 |
Total Assets | $520.37M | $510.77M | $499.94M | $497.74M |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $36.16M | $59.47M | $40.33M | $46.02M |
Free Cash Flow OCF − CapEx | $59.63M | $56.26M | $61.77M | $49.42M |
Shares Outstanding | 29.58M | 30.43M | 30.30M | 30.58M |